Pro Dex Inc (PDEX) stock

PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/306% below fair value

$65.66−1.76 (-2.61%)

Close on Nov 13, 2026Market cap $210.11MP/E 18.1Yield –

Pro Dex price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Pro Dex's price to sales ratio was 2.9× on Nov 11, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 1.2× to 3.5×, with a median of 1.7×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	2.9×	+1.1
2025	Dec 31, 2025	1.8×	−0.9
2024	Dec 31, 2024	2.7×	+1.4
2023	Dec 29, 2023	1.3×	−0.0
2022	Dec 30, 2022	1.3×	−0.8
2021	Dec 31, 2021	2.2×	−1.1
2020	Dec 31, 2020	3.3×	+0.8
2019	Dec 31, 2019	2.5×	+0.4
2018	Dec 31, 2018	2.1×	+0.8
2017	Dec 29, 2017	1.3×	+0.4
2016	Dec 30, 2016	0.9×	+0.3
2015	Dec 31, 2015	0.7×	−0.3
2014	Dec 31, 2014	1.0×	+0.2
2013	Dec 31, 2013	0.7×	+0.3
2012	Dec 31, 2012	0.4×	+0.1
2011	Dec 30, 2011	0.3×	–